tiger_老虎社区_美港股上老虎

ConanToh
2021-12-09

tiger

Pear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote>

Pear Therapeutics shares soared 75% in premarket trading. Prescription digital therapeutics company

Pear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote>

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":602586558,"tweetId":"602586558","gmtCreate":1639041697880,"gmtModify":1639041698086,"author":{"id":3578621924333526,"idStr":"3578621924333526","authorId":3578621924333526,"authorIdStr":"3578621924333526","name":"ConanToh","avatar":"https://static.tigerbbs.com/17bf1e09858b72f85e5e8efda2fbed84","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":11,"crmLevelSwitch":0,"individualDisplayBadges":[],"fanSize":19,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"extraTitle":"","html":"<html><head></head><body><p>tiger</p></body></html>","htmlText":"<html><head></head><body><p>tiger</p></body></html>","text":"tiger","highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/602586558","repostId":1117677376,"repostType":4,"repost":{"id":"1117677376","kind":"news","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1639041481,"share":"https://www.laohu8.com/m/news/1117677376?lang=zh_CN&edition=full","pubTime":"2021-12-09 17:18","market":"us","language":"en","title":"Pear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote>","url":"https://stock-news.laohu8.com/highlight/detail?id=1117677376","media":"Tiger Newspress","summary":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company","content":"<p>Pear Therapeutics shares soared 75% in premarket trading.</p><p><blockquote>Pear Therapeutics股价在盘前交易中飙升75%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Prescription digital therapeutics company&nbsp;Pear Therapeutics&nbsp;began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company&nbsp;Thimble Point Acquisition Corp.&nbsp;last week.</p><p><blockquote>处方数字治疗公司Pear Therapeutics上周完成与特殊目的收购公司Thimble Point Acquisition Corp.的合并后，周一开始在纳斯达克交易。</blockquote></p><p> The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p><p><blockquote>此次业务合并带来了约1.75亿美元的收入，该公司表示将用于资本化其数字治疗产品。它的股票代码为PEAR。</blockquote></p><p> \"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\"&nbsp;Pear President and CEO Dr. Corey McCann&nbsp;said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p><p><blockquote>Pear总裁兼首席执行官Corey McCann博士在一份声明中表示：“我和我的Pearmates很自豪能够继续在处方数字疗法的创造方面发挥领导作用。”“作为一家上市公司，我们的目标是通过进一步将我们的三种FDA授权的PDT商业化、扩大公共和私人付款人的采用以及推进我们的PDT产品线，来加速我们的愿景，即增加PDT[处方数字疗法]的获取。感谢所有我们的投资者支持我们的成功转型。”</blockquote></p><p></p>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote></title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote>\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time smaller\">2021-12-09 17:18</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<p>Pear Therapeutics shares soared 75% in premarket trading.</p><p><blockquote>Pear Therapeutics股价在盘前交易中飙升75%。</blockquote></p><p> <img src=\"https://static.tigerbbs.com/1aa8562d3d7942fc80a42167c422600c\" tg-width=\"851\" tg-height=\"619\" width=\"100%\" height=\"auto\"></p><p><blockquote></blockquote></p><p> Prescription digital therapeutics company&nbsp;Pear Therapeutics&nbsp;began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company&nbsp;Thimble Point Acquisition Corp.&nbsp;last week.</p><p><blockquote>处方数字治疗公司Pear Therapeutics上周完成与特殊目的收购公司Thimble Point Acquisition Corp.的合并后，周一开始在纳斯达克交易。</blockquote></p><p> The business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.</p><p><blockquote>此次业务合并带来了约1.75亿美元的收入，该公司表示将用于资本化其数字治疗产品。它的股票代码为PEAR。</blockquote></p><p> \"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\"&nbsp;Pear President and CEO Dr. Corey McCann&nbsp;said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"</p><p><blockquote>Pear总裁兼首席执行官Corey McCann博士在一份声明中表示：“我和我的Pearmates很自豪能够继续在处方数字疗法的创造方面发挥领导作用。”“作为一家上市公司，我们的目标是通过进一步将我们的三种FDA授权的PDT商业化、扩大公共和私人付款人的采用以及推进我们的PDT产品线，来加速我们的愿景，即增加PDT[处方数字疗法]的获取。感谢所有我们的投资者支持我们的成功转型。”</blockquote></p><p></p>\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"PEAR":"Pear Therapeutics"},"is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1117677376","content_text":"Pear Therapeutics shares soared 75% in premarket trading.\n\nPrescription digital therapeutics company Pear Therapeutics began trading on Nasdaq Monday after wrapping up its merger with special-purpose acquisition company Thimble Point Acquisition Corp. last week.\nThe business combination brought in about $175 million, which the company said will be used to capitalize its digital therapeutic products. It's trading under the ticker symbol PEAR.\n\"My Pearmates and I are proud to continue our leadership in the creation of prescription digital therapeutics,\" Pear President and CEO Dr. Corey McCann said in a statement. \"As a public company, we aim to accelerate our vision to increase access to PDTs [prescription digital therapeutics] by further commercializing our three FDA-authorized PDTs, expanding public and private payer adoption, and advancing our pipeline of PDTs. Thanks to all of our investors for supporting our successful transition.\"","news_type":1,"symbols_score_info":{"PEAR":0.9}},"isVote":1,"tweetType":1,"viewCount":2354,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":[],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":5,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}

Pear Therapeutics shares soared 75% in premarket trading<blockquote>Pear Therapeutics股价在盘前交易中飙升75%</blockquote>

评论（1）

热议股票